A Phase 1 First in Human, Multicentre, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose of CCX559 in Subjects with Solid Tumors [CL001_559]

  • Richardson, Gary (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

Effective start/end date1/09/2131/12/24


  • Solid tumours
  • Oncology
  • Clinical trial
  • Cancer